Exenatide Targets Beta Cells

Clinical studies have shown:

• Stimulates insulin secretion from beta cell

• Beta-cell effect glucose dependent

• Long-term improvements in indicators of beta-cell function

• Restores first phase insulin secretion

Previous slide

Next slide

Back to first slide

View graphic version